Trial intelligence / Profile preview

Antenatal corticosteroids before early-term elective cesarean section

ChiCTR2300074647Phase 3Not yet recruiting

Sponsor
Nanjing Maternal and Child Health Hospital
Start
Sep 2023
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of dexamethasone in respiratory distress syndrome (RDS), transient tachypnea of the newborn (TTN), hypoglycaemia and 1 more (2 arms), sponsored by Nanjing Maternal and Child Health Hospital. Primary endpoints: neonatal respiratory distress syndrome, transient tachypnea of the newborn and 3 more. Planned start Sep 2023; status: not yet recruiting.

02

Drugs

dexamethasone
03

Conditions

respiratory distress syndrome (RDS)transient tachypnea of the newborn (TTN)hypoglycaemiaasphyxia neonatorum

Beyond the preview

Go deeper on ChiCTR2300074647.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300074647.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call